KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Equity Average (2016 - 2025)

Historic Equity Average for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $80.4 billion.

  • Johnson & Johnson's Equity Average rose 1353.57% to $80.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $80.4 billion, marking a year-over-year increase of 1353.57%. This contributed to the annual value of $76.5 billion for FY2025, which is 910.43% up from last year.
  • As of Q4 2025, Johnson & Johnson's Equity Average stood at $80.4 billion, which was up 1353.57% from $78.9 billion recorded in Q3 2025.
  • Johnson & Johnson's Equity Average's 5-year high stood at $80.4 billion during Q4 2025, with a 5-year trough of $63.9 billion in Q1 2021.
  • Its 5-year average for Equity Average is $72.6 billion, with a median of $73.6 billion in 2023.
  • In the last 5 years, Johnson & Johnson's Equity Average skyrocketed by 1519.61% in 2022 and then crashed by 753.02% in 2023.
  • Johnson & Johnson's Equity Average (Quarter) stood at $69.9 billion in 2021, then increased by 7.94% to $75.5 billion in 2022, then fell by 7.26% to $70.0 billion in 2023, then increased by 1.18% to $70.8 billion in 2024, then grew by 13.54% to $80.4 billion in 2025.
  • Its last three reported values are $80.4 billion in Q4 2025, $78.9 billion for Q3 2025, and $78.3 billion during Q2 2025.